Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
JCO Precis Oncol
.
2019 May 10:3:PO.18.00335.
doi: 10.1200/PO.18.00335.
eCollection 2019.
Authors
David Casadevall
1
2
,
Xiaotong Li
1
,
Ryan L Powles
1
,
Vikram B Wali
1
,
Natalia Buza
1
,
Vasiliki Pelekanou
1
,
Arjun Dhawan
1
,
Julia Foldi
1
,
Borbala Szekely
1
3
,
Francesc Lopez-Giraldez
4
,
Christos Hatzis
1
,
Lajos Pusztai
1
Affiliations
1
Yale School of Medicine, New Haven, CT.
2
Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
3
National Institute of Oncology, Budapest, Hungary.
4
Yale Center for Genome Analysis, New Haven, CT.
PMID:
32914041
PMCID:
PMC7450962
DOI:
10.1200/PO.18.00335
No abstract available
Publication types
Case Reports